Global Point-of-care Testing (POCT) for Inflammatory Supply, Demand and Key Producers, 2023-2029
The global Point-of-care Testing (POCT) for Inflammatory market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Point-of-care Testing (POCT) for Inflammatory production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Point-of-care Testing (POCT) for Inflammatory, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Point-of-care Testing (POCT) for Inflammatory that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Point-of-care Testing (POCT) for Inflammatory total production and demand, 2018-2029, (K Units)
Global Point-of-care Testing (POCT) for Inflammatory total production value, 2018-2029, (USD Million)
Global Point-of-care Testing (POCT) for Inflammatory production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Inflammatory consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Point-of-care Testing (POCT) for Inflammatory domestic production, consumption, key domestic manufacturers and share
Global Point-of-care Testing (POCT) for Inflammatory production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Inflammatory production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Inflammatory production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Point-of-care Testing (POCT) for Inflammatory market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, Siemens Healthineers, BioMerieux, Bio-Rad Laboratories, Assure Tech, Guangzhou Wondfo Biotech Co.,Ltd., Wuhan Easy Diagnosis and Getein Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Point-of-care Testing (POCT) for Inflammatory market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Point-of-care Testing (POCT) for Inflammatory Market, By Region:
1. How big is the global Point-of-care Testing (POCT) for Inflammatory market?
2. What is the demand of the global Point-of-care Testing (POCT) for Inflammatory market?
3. What is the year over year growth of the global Point-of-care Testing (POCT) for Inflammatory market?
4. What is the production and production value of the global Point-of-care Testing (POCT) for Inflammatory market?
5. Who are the key producers in the global Point-of-care Testing (POCT) for Inflammatory market?
6. What are the growth factors driving the market demand?
This report studies the global Point-of-care Testing (POCT) for Inflammatory production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Point-of-care Testing (POCT) for Inflammatory, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Point-of-care Testing (POCT) for Inflammatory that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Point-of-care Testing (POCT) for Inflammatory total production and demand, 2018-2029, (K Units)
Global Point-of-care Testing (POCT) for Inflammatory total production value, 2018-2029, (USD Million)
Global Point-of-care Testing (POCT) for Inflammatory production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Inflammatory consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Point-of-care Testing (POCT) for Inflammatory domestic production, consumption, key domestic manufacturers and share
Global Point-of-care Testing (POCT) for Inflammatory production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Inflammatory production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Inflammatory production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Point-of-care Testing (POCT) for Inflammatory market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, Siemens Healthineers, BioMerieux, Bio-Rad Laboratories, Assure Tech, Guangzhou Wondfo Biotech Co.,Ltd., Wuhan Easy Diagnosis and Getein Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Point-of-care Testing (POCT) for Inflammatory market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Point-of-care Testing (POCT) for Inflammatory Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Based on Immunochromatography
- Based on Chemiluminescence
- Based on Microfluidic Chip
- C-Reactive Protein (CRP) Test
- Procalcitonin (PCT) Test
- Interleukin 6 (IL-6) Test
- Serum amyloid A (SAA) Test
- Others
- Roche
- Abbott
- Siemens Healthineers
- BioMerieux
- Bio-Rad Laboratories
- Assure Tech
- Guangzhou Wondfo Biotech Co.,Ltd.
- Wuhan Easy Diagnosis
- Getein Biotech
- Beijing Hotgen Biotech Co.,ltd.
- Shanghai Upper Bio-Tech Pharma Co.,Ltd.
- Qingdao Hightop Biotech Co., Ltd.
- Goldsite Diagnostics Inc.
- Genrui Biotech Inc
- Hipro Biotechnology CO.,LTD
1. How big is the global Point-of-care Testing (POCT) for Inflammatory market?
2. What is the demand of the global Point-of-care Testing (POCT) for Inflammatory market?
3. What is the year over year growth of the global Point-of-care Testing (POCT) for Inflammatory market?
4. What is the production and production value of the global Point-of-care Testing (POCT) for Inflammatory market?
5. Who are the key producers in the global Point-of-care Testing (POCT) for Inflammatory market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Point-of-care Testing (POCT) for Inflammatory Introduction
1.2 World Point-of-care Testing (POCT) for Inflammatory Supply & Forecast
1.2.1 World Point-of-care Testing (POCT) for Inflammatory Production Value (2018 & 2022 & 2029)
1.2.2 World Point-of-care Testing (POCT) for Inflammatory Production (2018-2029)
1.2.3 World Point-of-care Testing (POCT) for Inflammatory Pricing Trends (2018-2029)
1.3 World Point-of-care Testing (POCT) for Inflammatory Production by Region (Based on Production Site)
1.3.1 World Point-of-care Testing (POCT) for Inflammatory Production Value by Region (2018-2029)
1.3.2 World Point-of-care Testing (POCT) for Inflammatory Production by Region (2018-2029)
1.3.3 World Point-of-care Testing (POCT) for Inflammatory Average Price by Region (2018-2029)
1.3.4 North America Point-of-care Testing (POCT) for Inflammatory Production (2018-2029)
1.3.5 Europe Point-of-care Testing (POCT) for Inflammatory Production (2018-2029)
1.3.6 China Point-of-care Testing (POCT) for Inflammatory Production (2018-2029)
1.3.7 Japan Point-of-care Testing (POCT) for Inflammatory Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Point-of-care Testing (POCT) for Inflammatory Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Point-of-care Testing (POCT) for Inflammatory Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Point-of-care Testing (POCT) for Inflammatory Demand (2018-2029)
2.2 World Point-of-care Testing (POCT) for Inflammatory Consumption by Region
2.2.1 World Point-of-care Testing (POCT) for Inflammatory Consumption by Region (2018-2023)
2.2.2 World Point-of-care Testing (POCT) for Inflammatory Consumption Forecast by Region (2024-2029)
2.3 United States Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029)
2.4 China Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029)
2.5 Europe Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029)
2.6 Japan Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029)
2.7 South Korea Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029)
2.8 ASEAN Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029)
2.9 India Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029)
3 WORLD POINT-OF-CARE TESTING (POCT) FOR INFLAMMATORY MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Point-of-care Testing (POCT) for Inflammatory Production Value by Manufacturer (2018-2023)
3.2 World Point-of-care Testing (POCT) for Inflammatory Production by Manufacturer (2018-2023)
3.3 World Point-of-care Testing (POCT) for Inflammatory Average Price by Manufacturer (2018-2023)
3.4 Point-of-care Testing (POCT) for Inflammatory Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Point-of-care Testing (POCT) for Inflammatory Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Point-of-care Testing (POCT) for Inflammatory in 2022
3.5.3 Global Concentration Ratios (CR8) for Point-of-care Testing (POCT) for Inflammatory in 2022
3.6 Point-of-care Testing (POCT) for Inflammatory Market: Overall Company Footprint Analysis
3.6.1 Point-of-care Testing (POCT) for Inflammatory Market: Region Footprint
3.6.2 Point-of-care Testing (POCT) for Inflammatory Market: Company Product Type Footprint
3.6.3 Point-of-care Testing (POCT) for Inflammatory Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Value Comparison
4.1.1 United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Comparison
4.2.1 United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Point-of-care Testing (POCT) for Inflammatory Consumption Comparison
4.3.1 United States VS China: Point-of-care Testing (POCT) for Inflammatory Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Point-of-care Testing (POCT) for Inflammatory Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Point-of-care Testing (POCT) for Inflammatory Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Point-of-care Testing (POCT) for Inflammatory Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value (2018-2023)
4.4.3 United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production (2018-2023)
4.5 China Based Point-of-care Testing (POCT) for Inflammatory Manufacturers and Market Share
4.5.1 China Based Point-of-care Testing (POCT) for Inflammatory Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value (2018-2023)
4.5.3 China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production (2018-2023)
4.6 Rest of World Based Point-of-care Testing (POCT) for Inflammatory Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Point-of-care Testing (POCT) for Inflammatory Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Point-of-care Testing (POCT) for Inflammatory Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Based on Immunochromatography
5.2.2 Based on Chemiluminescence
5.2.3 Based on Microfluidic Chip
5.3 Market Segment by Type
5.3.1 World Point-of-care Testing (POCT) for Inflammatory Production by Type (2018-2029)
5.3.2 World Point-of-care Testing (POCT) for Inflammatory Production Value by Type (2018-2029)
5.3.3 World Point-of-care Testing (POCT) for Inflammatory Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Point-of-care Testing (POCT) for Inflammatory Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 C-Reactive Protein (CRP) Test
6.2.2 Procalcitonin (PCT) Test
6.2.3 Interleukin 6 (IL-6) Test
6.2.4 Serum amyloid A (SAA) Test
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Point-of-care Testing (POCT) for Inflammatory Production by Application (2018-2029)
6.3.2 World Point-of-care Testing (POCT) for Inflammatory Production Value by Application (2018-2029)
6.3.3 World Point-of-care Testing (POCT) for Inflammatory Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Point-of-care Testing (POCT) for Inflammatory Product and Services
7.1.4 Roche Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Abbott
7.2.1 Abbott Details
7.2.2 Abbott Major Business
7.2.3 Abbott Point-of-care Testing (POCT) for Inflammatory Product and Services
7.2.4 Abbott Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Abbott Recent Developments/Updates
7.2.6 Abbott Competitive Strengths & Weaknesses
7.3 Siemens Healthineers
7.3.1 Siemens Healthineers Details
7.3.2 Siemens Healthineers Major Business
7.3.3 Siemens Healthineers Point-of-care Testing (POCT) for Inflammatory Product and Services
7.3.4 Siemens Healthineers Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Siemens Healthineers Recent Developments/Updates
7.3.6 Siemens Healthineers Competitive Strengths & Weaknesses
7.4 BioMerieux
7.4.1 BioMerieux Details
7.4.2 BioMerieux Major Business
7.4.3 BioMerieux Point-of-care Testing (POCT) for Inflammatory Product and Services
7.4.4 BioMerieux Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 BioMerieux Recent Developments/Updates
7.4.6 BioMerieux Competitive Strengths & Weaknesses
7.5 Bio-Rad Laboratories
7.5.1 Bio-Rad Laboratories Details
7.5.2 Bio-Rad Laboratories Major Business
7.5.3 Bio-Rad Laboratories Point-of-care Testing (POCT) for Inflammatory Product and Services
7.5.4 Bio-Rad Laboratories Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Bio-Rad Laboratories Recent Developments/Updates
7.5.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
7.6 Assure Tech
7.6.1 Assure Tech Details
7.6.2 Assure Tech Major Business
7.6.3 Assure Tech Point-of-care Testing (POCT) for Inflammatory Product and Services
7.6.4 Assure Tech Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Assure Tech Recent Developments/Updates
7.6.6 Assure Tech Competitive Strengths & Weaknesses
7.7 Guangzhou Wondfo Biotech Co.,Ltd.
7.7.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
7.7.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
7.7.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
7.7.4 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
7.7.6 Guangzhou Wondfo Biotech Co.,Ltd. Competitive Strengths & Weaknesses
7.8 Wuhan Easy Diagnosis
7.8.1 Wuhan Easy Diagnosis Details
7.8.2 Wuhan Easy Diagnosis Major Business
7.8.3 Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Inflammatory Product and Services
7.8.4 Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Wuhan Easy Diagnosis Recent Developments/Updates
7.8.6 Wuhan Easy Diagnosis Competitive Strengths & Weaknesses
7.9 Getein Biotech
7.9.1 Getein Biotech Details
7.9.2 Getein Biotech Major Business
7.9.3 Getein Biotech Point-of-care Testing (POCT) for Inflammatory Product and Services
7.9.4 Getein Biotech Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Getein Biotech Recent Developments/Updates
7.9.6 Getein Biotech Competitive Strengths & Weaknesses
7.10 Beijing Hotgen Biotech Co.,ltd.
7.10.1 Beijing Hotgen Biotech Co.,ltd. Details
7.10.2 Beijing Hotgen Biotech Co.,ltd. Major Business
7.10.3 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
7.10.4 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
7.10.6 Beijing Hotgen Biotech Co.,ltd. Competitive Strengths & Weaknesses
7.11 Shanghai Upper Bio-Tech Pharma Co.,Ltd.
7.11.1 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Details
7.11.2 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Major Business
7.11.3 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
7.11.4 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Recent Developments/Updates
7.11.6 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Competitive Strengths & Weaknesses
7.12 Qingdao Hightop Biotech Co., Ltd.
7.12.1 Qingdao Hightop Biotech Co., Ltd. Details
7.12.2 Qingdao Hightop Biotech Co., Ltd. Major Business
7.12.3 Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
7.12.4 Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Qingdao Hightop Biotech Co., Ltd. Recent Developments/Updates
7.12.6 Qingdao Hightop Biotech Co., Ltd. Competitive Strengths & Weaknesses
7.13 Goldsite Diagnostics Inc.
7.13.1 Goldsite Diagnostics Inc. Details
7.13.2 Goldsite Diagnostics Inc. Major Business
7.13.3 Goldsite Diagnostics Inc. Point-of-care Testing (POCT) for Inflammatory Product and Services
7.13.4 Goldsite Diagnostics Inc. Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Goldsite Diagnostics Inc. Recent Developments/Updates
7.13.6 Goldsite Diagnostics Inc. Competitive Strengths & Weaknesses
7.14 Genrui Biotech Inc
7.14.1 Genrui Biotech Inc Details
7.14.2 Genrui Biotech Inc Major Business
7.14.3 Genrui Biotech Inc Point-of-care Testing (POCT) for Inflammatory Product and Services
7.14.4 Genrui Biotech Inc Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Genrui Biotech Inc Recent Developments/Updates
7.14.6 Genrui Biotech Inc Competitive Strengths & Weaknesses
7.15 Hipro Biotechnology CO.,LTD
7.15.1 Hipro Biotechnology CO.,LTD Details
7.15.2 Hipro Biotechnology CO.,LTD Major Business
7.15.3 Hipro Biotechnology CO.,LTD Point-of-care Testing (POCT) for Inflammatory Product and Services
7.15.4 Hipro Biotechnology CO.,LTD Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Hipro Biotechnology CO.,LTD Recent Developments/Updates
7.15.6 Hipro Biotechnology CO.,LTD Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Point-of-care Testing (POCT) for Inflammatory Industry Chain
8.2 Point-of-care Testing (POCT) for Inflammatory Upstream Analysis
8.2.1 Point-of-care Testing (POCT) for Inflammatory Core Raw Materials
8.2.2 Main Manufacturers of Point-of-care Testing (POCT) for Inflammatory Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Point-of-care Testing (POCT) for Inflammatory Production Mode
8.6 Point-of-care Testing (POCT) for Inflammatory Procurement Model
8.7 Point-of-care Testing (POCT) for Inflammatory Industry Sales Model and Sales Channels
8.7.1 Point-of-care Testing (POCT) for Inflammatory Sales Model
8.7.2 Point-of-care Testing (POCT) for Inflammatory Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Point-of-care Testing (POCT) for Inflammatory Introduction
1.2 World Point-of-care Testing (POCT) for Inflammatory Supply & Forecast
1.2.1 World Point-of-care Testing (POCT) for Inflammatory Production Value (2018 & 2022 & 2029)
1.2.2 World Point-of-care Testing (POCT) for Inflammatory Production (2018-2029)
1.2.3 World Point-of-care Testing (POCT) for Inflammatory Pricing Trends (2018-2029)
1.3 World Point-of-care Testing (POCT) for Inflammatory Production by Region (Based on Production Site)
1.3.1 World Point-of-care Testing (POCT) for Inflammatory Production Value by Region (2018-2029)
1.3.2 World Point-of-care Testing (POCT) for Inflammatory Production by Region (2018-2029)
1.3.3 World Point-of-care Testing (POCT) for Inflammatory Average Price by Region (2018-2029)
1.3.4 North America Point-of-care Testing (POCT) for Inflammatory Production (2018-2029)
1.3.5 Europe Point-of-care Testing (POCT) for Inflammatory Production (2018-2029)
1.3.6 China Point-of-care Testing (POCT) for Inflammatory Production (2018-2029)
1.3.7 Japan Point-of-care Testing (POCT) for Inflammatory Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Point-of-care Testing (POCT) for Inflammatory Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Point-of-care Testing (POCT) for Inflammatory Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Point-of-care Testing (POCT) for Inflammatory Demand (2018-2029)
2.2 World Point-of-care Testing (POCT) for Inflammatory Consumption by Region
2.2.1 World Point-of-care Testing (POCT) for Inflammatory Consumption by Region (2018-2023)
2.2.2 World Point-of-care Testing (POCT) for Inflammatory Consumption Forecast by Region (2024-2029)
2.3 United States Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029)
2.4 China Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029)
2.5 Europe Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029)
2.6 Japan Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029)
2.7 South Korea Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029)
2.8 ASEAN Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029)
2.9 India Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029)
3 WORLD POINT-OF-CARE TESTING (POCT) FOR INFLAMMATORY MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Point-of-care Testing (POCT) for Inflammatory Production Value by Manufacturer (2018-2023)
3.2 World Point-of-care Testing (POCT) for Inflammatory Production by Manufacturer (2018-2023)
3.3 World Point-of-care Testing (POCT) for Inflammatory Average Price by Manufacturer (2018-2023)
3.4 Point-of-care Testing (POCT) for Inflammatory Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Point-of-care Testing (POCT) for Inflammatory Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Point-of-care Testing (POCT) for Inflammatory in 2022
3.5.3 Global Concentration Ratios (CR8) for Point-of-care Testing (POCT) for Inflammatory in 2022
3.6 Point-of-care Testing (POCT) for Inflammatory Market: Overall Company Footprint Analysis
3.6.1 Point-of-care Testing (POCT) for Inflammatory Market: Region Footprint
3.6.2 Point-of-care Testing (POCT) for Inflammatory Market: Company Product Type Footprint
3.6.3 Point-of-care Testing (POCT) for Inflammatory Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Value Comparison
4.1.1 United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Comparison
4.2.1 United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Point-of-care Testing (POCT) for Inflammatory Consumption Comparison
4.3.1 United States VS China: Point-of-care Testing (POCT) for Inflammatory Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Point-of-care Testing (POCT) for Inflammatory Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Point-of-care Testing (POCT) for Inflammatory Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Point-of-care Testing (POCT) for Inflammatory Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value (2018-2023)
4.4.3 United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production (2018-2023)
4.5 China Based Point-of-care Testing (POCT) for Inflammatory Manufacturers and Market Share
4.5.1 China Based Point-of-care Testing (POCT) for Inflammatory Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value (2018-2023)
4.5.3 China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production (2018-2023)
4.6 Rest of World Based Point-of-care Testing (POCT) for Inflammatory Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Point-of-care Testing (POCT) for Inflammatory Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Point-of-care Testing (POCT) for Inflammatory Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Based on Immunochromatography
5.2.2 Based on Chemiluminescence
5.2.3 Based on Microfluidic Chip
5.3 Market Segment by Type
5.3.1 World Point-of-care Testing (POCT) for Inflammatory Production by Type (2018-2029)
5.3.2 World Point-of-care Testing (POCT) for Inflammatory Production Value by Type (2018-2029)
5.3.3 World Point-of-care Testing (POCT) for Inflammatory Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Point-of-care Testing (POCT) for Inflammatory Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 C-Reactive Protein (CRP) Test
6.2.2 Procalcitonin (PCT) Test
6.2.3 Interleukin 6 (IL-6) Test
6.2.4 Serum amyloid A (SAA) Test
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Point-of-care Testing (POCT) for Inflammatory Production by Application (2018-2029)
6.3.2 World Point-of-care Testing (POCT) for Inflammatory Production Value by Application (2018-2029)
6.3.3 World Point-of-care Testing (POCT) for Inflammatory Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Point-of-care Testing (POCT) for Inflammatory Product and Services
7.1.4 Roche Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Abbott
7.2.1 Abbott Details
7.2.2 Abbott Major Business
7.2.3 Abbott Point-of-care Testing (POCT) for Inflammatory Product and Services
7.2.4 Abbott Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Abbott Recent Developments/Updates
7.2.6 Abbott Competitive Strengths & Weaknesses
7.3 Siemens Healthineers
7.3.1 Siemens Healthineers Details
7.3.2 Siemens Healthineers Major Business
7.3.3 Siemens Healthineers Point-of-care Testing (POCT) for Inflammatory Product and Services
7.3.4 Siemens Healthineers Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Siemens Healthineers Recent Developments/Updates
7.3.6 Siemens Healthineers Competitive Strengths & Weaknesses
7.4 BioMerieux
7.4.1 BioMerieux Details
7.4.2 BioMerieux Major Business
7.4.3 BioMerieux Point-of-care Testing (POCT) for Inflammatory Product and Services
7.4.4 BioMerieux Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 BioMerieux Recent Developments/Updates
7.4.6 BioMerieux Competitive Strengths & Weaknesses
7.5 Bio-Rad Laboratories
7.5.1 Bio-Rad Laboratories Details
7.5.2 Bio-Rad Laboratories Major Business
7.5.3 Bio-Rad Laboratories Point-of-care Testing (POCT) for Inflammatory Product and Services
7.5.4 Bio-Rad Laboratories Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Bio-Rad Laboratories Recent Developments/Updates
7.5.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
7.6 Assure Tech
7.6.1 Assure Tech Details
7.6.2 Assure Tech Major Business
7.6.3 Assure Tech Point-of-care Testing (POCT) for Inflammatory Product and Services
7.6.4 Assure Tech Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Assure Tech Recent Developments/Updates
7.6.6 Assure Tech Competitive Strengths & Weaknesses
7.7 Guangzhou Wondfo Biotech Co.,Ltd.
7.7.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
7.7.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
7.7.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
7.7.4 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
7.7.6 Guangzhou Wondfo Biotech Co.,Ltd. Competitive Strengths & Weaknesses
7.8 Wuhan Easy Diagnosis
7.8.1 Wuhan Easy Diagnosis Details
7.8.2 Wuhan Easy Diagnosis Major Business
7.8.3 Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Inflammatory Product and Services
7.8.4 Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Wuhan Easy Diagnosis Recent Developments/Updates
7.8.6 Wuhan Easy Diagnosis Competitive Strengths & Weaknesses
7.9 Getein Biotech
7.9.1 Getein Biotech Details
7.9.2 Getein Biotech Major Business
7.9.3 Getein Biotech Point-of-care Testing (POCT) for Inflammatory Product and Services
7.9.4 Getein Biotech Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Getein Biotech Recent Developments/Updates
7.9.6 Getein Biotech Competitive Strengths & Weaknesses
7.10 Beijing Hotgen Biotech Co.,ltd.
7.10.1 Beijing Hotgen Biotech Co.,ltd. Details
7.10.2 Beijing Hotgen Biotech Co.,ltd. Major Business
7.10.3 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
7.10.4 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
7.10.6 Beijing Hotgen Biotech Co.,ltd. Competitive Strengths & Weaknesses
7.11 Shanghai Upper Bio-Tech Pharma Co.,Ltd.
7.11.1 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Details
7.11.2 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Major Business
7.11.3 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
7.11.4 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Recent Developments/Updates
7.11.6 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Competitive Strengths & Weaknesses
7.12 Qingdao Hightop Biotech Co., Ltd.
7.12.1 Qingdao Hightop Biotech Co., Ltd. Details
7.12.2 Qingdao Hightop Biotech Co., Ltd. Major Business
7.12.3 Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
7.12.4 Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Qingdao Hightop Biotech Co., Ltd. Recent Developments/Updates
7.12.6 Qingdao Hightop Biotech Co., Ltd. Competitive Strengths & Weaknesses
7.13 Goldsite Diagnostics Inc.
7.13.1 Goldsite Diagnostics Inc. Details
7.13.2 Goldsite Diagnostics Inc. Major Business
7.13.3 Goldsite Diagnostics Inc. Point-of-care Testing (POCT) for Inflammatory Product and Services
7.13.4 Goldsite Diagnostics Inc. Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Goldsite Diagnostics Inc. Recent Developments/Updates
7.13.6 Goldsite Diagnostics Inc. Competitive Strengths & Weaknesses
7.14 Genrui Biotech Inc
7.14.1 Genrui Biotech Inc Details
7.14.2 Genrui Biotech Inc Major Business
7.14.3 Genrui Biotech Inc Point-of-care Testing (POCT) for Inflammatory Product and Services
7.14.4 Genrui Biotech Inc Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Genrui Biotech Inc Recent Developments/Updates
7.14.6 Genrui Biotech Inc Competitive Strengths & Weaknesses
7.15 Hipro Biotechnology CO.,LTD
7.15.1 Hipro Biotechnology CO.,LTD Details
7.15.2 Hipro Biotechnology CO.,LTD Major Business
7.15.3 Hipro Biotechnology CO.,LTD Point-of-care Testing (POCT) for Inflammatory Product and Services
7.15.4 Hipro Biotechnology CO.,LTD Point-of-care Testing (POCT) for Inflammatory Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Hipro Biotechnology CO.,LTD Recent Developments/Updates
7.15.6 Hipro Biotechnology CO.,LTD Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Point-of-care Testing (POCT) for Inflammatory Industry Chain
8.2 Point-of-care Testing (POCT) for Inflammatory Upstream Analysis
8.2.1 Point-of-care Testing (POCT) for Inflammatory Core Raw Materials
8.2.2 Main Manufacturers of Point-of-care Testing (POCT) for Inflammatory Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Point-of-care Testing (POCT) for Inflammatory Production Mode
8.6 Point-of-care Testing (POCT) for Inflammatory Procurement Model
8.7 Point-of-care Testing (POCT) for Inflammatory Industry Sales Model and Sales Channels
8.7.1 Point-of-care Testing (POCT) for Inflammatory Sales Model
8.7.2 Point-of-care Testing (POCT) for Inflammatory Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Point-of-care Testing (POCT) for Inflammatory Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Point-of-care Testing (POCT) for Inflammatory Production Value by Region (2018-2023) & (USD Million)
Table 3. World Point-of-care Testing (POCT) for Inflammatory Production Value by Region (2024-2029) & (USD Million)
Table 4. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Region (2018-2023)
Table 5. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Region (2024-2029)
Table 6. World Point-of-care Testing (POCT) for Inflammatory Production by Region (2018-2023) & (K Units)
Table 7. World Point-of-care Testing (POCT) for Inflammatory Production by Region (2024-2029) & (K Units)
Table 8. World Point-of-care Testing (POCT) for Inflammatory Production Market Share by Region (2018-2023)
Table 9. World Point-of-care Testing (POCT) for Inflammatory Production Market Share by Region (2024-2029)
Table 10. World Point-of-care Testing (POCT) for Inflammatory Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Point-of-care Testing (POCT) for Inflammatory Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Point-of-care Testing (POCT) for Inflammatory Major Market Trends
Table 13. World Point-of-care Testing (POCT) for Inflammatory Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Point-of-care Testing (POCT) for Inflammatory Consumption by Region (2018-2023) & (K Units)
Table 15. World Point-of-care Testing (POCT) for Inflammatory Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Point-of-care Testing (POCT) for Inflammatory Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Point-of-care Testing (POCT) for Inflammatory Producers in 2022
Table 18. World Point-of-care Testing (POCT) for Inflammatory Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Point-of-care Testing (POCT) for Inflammatory Producers in 2022
Table 20. World Point-of-care Testing (POCT) for Inflammatory Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Point-of-care Testing (POCT) for Inflammatory Company Evaluation Quadrant
Table 22. World Point-of-care Testing (POCT) for Inflammatory Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Point-of-care Testing (POCT) for Inflammatory Production Site of Key Manufacturer
Table 24. Point-of-care Testing (POCT) for Inflammatory Market: Company Product Type Footprint
Table 25. Point-of-care Testing (POCT) for Inflammatory Market: Company Product Application Footprint
Table 26. Point-of-care Testing (POCT) for Inflammatory Competitive Factors
Table 27. Point-of-care Testing (POCT) for Inflammatory New Entrant and Capacity Expansion Plans
Table 28. Point-of-care Testing (POCT) for Inflammatory Mergers & Acquisitions Activity
Table 29. United States VS China Point-of-care Testing (POCT) for Inflammatory Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Point-of-care Testing (POCT) for Inflammatory Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Point-of-care Testing (POCT) for Inflammatory Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Point-of-care Testing (POCT) for Inflammatory Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Market Share (2018-2023)
Table 37. China Based Point-of-care Testing (POCT) for Inflammatory Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Market Share (2018-2023)
Table 42. Rest of World Based Point-of-care Testing (POCT) for Inflammatory Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Market Share (2018-2023)
Table 47. World Point-of-care Testing (POCT) for Inflammatory Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Point-of-care Testing (POCT) for Inflammatory Production by Type (2018-2023) & (K Units)
Table 49. World Point-of-care Testing (POCT) for Inflammatory Production by Type (2024-2029) & (K Units)
Table 50. World Point-of-care Testing (POCT) for Inflammatory Production Value by Type (2018-2023) & (USD Million)
Table 51. World Point-of-care Testing (POCT) for Inflammatory Production Value by Type (2024-2029) & (USD Million)
Table 52. World Point-of-care Testing (POCT) for Inflammatory Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Point-of-care Testing (POCT) for Inflammatory Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Point-of-care Testing (POCT) for Inflammatory Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Point-of-care Testing (POCT) for Inflammatory Production by Application (2018-2023) & (K Units)
Table 56. World Point-of-care Testing (POCT) for Inflammatory Production by Application (2024-2029) & (K Units)
Table 57. World Point-of-care Testing (POCT) for Inflammatory Production Value by Application (2018-2023) & (USD Million)
Table 58. World Point-of-care Testing (POCT) for Inflammatory Production Value by Application (2024-2029) & (USD Million)
Table 59. World Point-of-care Testing (POCT) for Inflammatory Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Point-of-care Testing (POCT) for Inflammatory Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Roche Basic Information, Manufacturing Base and Competitors
Table 62. Roche Major Business
Table 63. Roche Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 64. Roche Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Roche Recent Developments/Updates
Table 66. Roche Competitive Strengths & Weaknesses
Table 67. Abbott Basic Information, Manufacturing Base and Competitors
Table 68. Abbott Major Business
Table 69. Abbott Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 70. Abbott Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Abbott Recent Developments/Updates
Table 72. Abbott Competitive Strengths & Weaknesses
Table 73. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 74. Siemens Healthineers Major Business
Table 75. Siemens Healthineers Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 76. Siemens Healthineers Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Siemens Healthineers Recent Developments/Updates
Table 78. Siemens Healthineers Competitive Strengths & Weaknesses
Table 79. BioMerieux Basic Information, Manufacturing Base and Competitors
Table 80. BioMerieux Major Business
Table 81. BioMerieux Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 82. BioMerieux Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. BioMerieux Recent Developments/Updates
Table 84. BioMerieux Competitive Strengths & Weaknesses
Table 85. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 86. Bio-Rad Laboratories Major Business
Table 87. Bio-Rad Laboratories Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 88. Bio-Rad Laboratories Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Bio-Rad Laboratories Recent Developments/Updates
Table 90. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 91. Assure Tech Basic Information, Manufacturing Base and Competitors
Table 92. Assure Tech Major Business
Table 93. Assure Tech Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 94. Assure Tech Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Assure Tech Recent Developments/Updates
Table 96. Assure Tech Competitive Strengths & Weaknesses
Table 97. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 98. Guangzhou Wondfo Biotech Co.,Ltd. Major Business
Table 99. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 100. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
Table 102. Guangzhou Wondfo Biotech Co.,Ltd. Competitive Strengths & Weaknesses
Table 103. Wuhan Easy Diagnosis Basic Information, Manufacturing Base and Competitors
Table 104. Wuhan Easy Diagnosis Major Business
Table 105. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 106. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Wuhan Easy Diagnosis Recent Developments/Updates
Table 108. Wuhan Easy Diagnosis Competitive Strengths & Weaknesses
Table 109. Getein Biotech Basic Information, Manufacturing Base and Competitors
Table 110. Getein Biotech Major Business
Table 111. Getein Biotech Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 112. Getein Biotech Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Getein Biotech Recent Developments/Updates
Table 114. Getein Biotech Competitive Strengths & Weaknesses
Table 115. Beijing Hotgen Biotech Co.,ltd. Basic Information, Manufacturing Base and Competitors
Table 116. Beijing Hotgen Biotech Co.,ltd. Major Business
Table 117. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 118. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
Table 120. Beijing Hotgen Biotech Co.,ltd. Competitive Strengths & Weaknesses
Table 121. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 122. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Major Business
Table 123. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 124. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Recent Developments/Updates
Table 126. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Competitive Strengths & Weaknesses
Table 127. Qingdao Hightop Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 128. Qingdao Hightop Biotech Co., Ltd. Major Business
Table 129. Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 130. Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Qingdao Hightop Biotech Co., Ltd. Recent Developments/Updates
Table 132. Qingdao Hightop Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 133. Goldsite Diagnostics Inc. Basic Information, Manufacturing Base and Competitors
Table 134. Goldsite Diagnostics Inc. Major Business
Table 135. Goldsite Diagnostics Inc. Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 136. Goldsite Diagnostics Inc. Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Goldsite Diagnostics Inc. Recent Developments/Updates
Table 138. Goldsite Diagnostics Inc. Competitive Strengths & Weaknesses
Table 139. Genrui Biotech Inc Basic Information, Manufacturing Base and Competitors
Table 140. Genrui Biotech Inc Major Business
Table 141. Genrui Biotech Inc Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 142. Genrui Biotech Inc Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Genrui Biotech Inc Recent Developments/Updates
Table 144. Hipro Biotechnology CO.,LTD Basic Information, Manufacturing Base and Competitors
Table 145. Hipro Biotechnology CO.,LTD Major Business
Table 146. Hipro Biotechnology CO.,LTD Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 147. Hipro Biotechnology CO.,LTD Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Point-of-care Testing (POCT) for Inflammatory Upstream (Raw Materials)
Table 149. Point-of-care Testing (POCT) for Inflammatory Typical Customers
Table 150. Point-of-care Testing (POCT) for Inflammatory Typical Distributors
Table 1. World Point-of-care Testing (POCT) for Inflammatory Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Point-of-care Testing (POCT) for Inflammatory Production Value by Region (2018-2023) & (USD Million)
Table 3. World Point-of-care Testing (POCT) for Inflammatory Production Value by Region (2024-2029) & (USD Million)
Table 4. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Region (2018-2023)
Table 5. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Region (2024-2029)
Table 6. World Point-of-care Testing (POCT) for Inflammatory Production by Region (2018-2023) & (K Units)
Table 7. World Point-of-care Testing (POCT) for Inflammatory Production by Region (2024-2029) & (K Units)
Table 8. World Point-of-care Testing (POCT) for Inflammatory Production Market Share by Region (2018-2023)
Table 9. World Point-of-care Testing (POCT) for Inflammatory Production Market Share by Region (2024-2029)
Table 10. World Point-of-care Testing (POCT) for Inflammatory Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Point-of-care Testing (POCT) for Inflammatory Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Point-of-care Testing (POCT) for Inflammatory Major Market Trends
Table 13. World Point-of-care Testing (POCT) for Inflammatory Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Point-of-care Testing (POCT) for Inflammatory Consumption by Region (2018-2023) & (K Units)
Table 15. World Point-of-care Testing (POCT) for Inflammatory Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Point-of-care Testing (POCT) for Inflammatory Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Point-of-care Testing (POCT) for Inflammatory Producers in 2022
Table 18. World Point-of-care Testing (POCT) for Inflammatory Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Point-of-care Testing (POCT) for Inflammatory Producers in 2022
Table 20. World Point-of-care Testing (POCT) for Inflammatory Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Point-of-care Testing (POCT) for Inflammatory Company Evaluation Quadrant
Table 22. World Point-of-care Testing (POCT) for Inflammatory Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Point-of-care Testing (POCT) for Inflammatory Production Site of Key Manufacturer
Table 24. Point-of-care Testing (POCT) for Inflammatory Market: Company Product Type Footprint
Table 25. Point-of-care Testing (POCT) for Inflammatory Market: Company Product Application Footprint
Table 26. Point-of-care Testing (POCT) for Inflammatory Competitive Factors
Table 27. Point-of-care Testing (POCT) for Inflammatory New Entrant and Capacity Expansion Plans
Table 28. Point-of-care Testing (POCT) for Inflammatory Mergers & Acquisitions Activity
Table 29. United States VS China Point-of-care Testing (POCT) for Inflammatory Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Point-of-care Testing (POCT) for Inflammatory Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Point-of-care Testing (POCT) for Inflammatory Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Point-of-care Testing (POCT) for Inflammatory Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Market Share (2018-2023)
Table 37. China Based Point-of-care Testing (POCT) for Inflammatory Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Market Share (2018-2023)
Table 42. Rest of World Based Point-of-care Testing (POCT) for Inflammatory Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Market Share (2018-2023)
Table 47. World Point-of-care Testing (POCT) for Inflammatory Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Point-of-care Testing (POCT) for Inflammatory Production by Type (2018-2023) & (K Units)
Table 49. World Point-of-care Testing (POCT) for Inflammatory Production by Type (2024-2029) & (K Units)
Table 50. World Point-of-care Testing (POCT) for Inflammatory Production Value by Type (2018-2023) & (USD Million)
Table 51. World Point-of-care Testing (POCT) for Inflammatory Production Value by Type (2024-2029) & (USD Million)
Table 52. World Point-of-care Testing (POCT) for Inflammatory Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Point-of-care Testing (POCT) for Inflammatory Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Point-of-care Testing (POCT) for Inflammatory Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Point-of-care Testing (POCT) for Inflammatory Production by Application (2018-2023) & (K Units)
Table 56. World Point-of-care Testing (POCT) for Inflammatory Production by Application (2024-2029) & (K Units)
Table 57. World Point-of-care Testing (POCT) for Inflammatory Production Value by Application (2018-2023) & (USD Million)
Table 58. World Point-of-care Testing (POCT) for Inflammatory Production Value by Application (2024-2029) & (USD Million)
Table 59. World Point-of-care Testing (POCT) for Inflammatory Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Point-of-care Testing (POCT) for Inflammatory Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Roche Basic Information, Manufacturing Base and Competitors
Table 62. Roche Major Business
Table 63. Roche Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 64. Roche Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Roche Recent Developments/Updates
Table 66. Roche Competitive Strengths & Weaknesses
Table 67. Abbott Basic Information, Manufacturing Base and Competitors
Table 68. Abbott Major Business
Table 69. Abbott Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 70. Abbott Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Abbott Recent Developments/Updates
Table 72. Abbott Competitive Strengths & Weaknesses
Table 73. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 74. Siemens Healthineers Major Business
Table 75. Siemens Healthineers Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 76. Siemens Healthineers Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Siemens Healthineers Recent Developments/Updates
Table 78. Siemens Healthineers Competitive Strengths & Weaknesses
Table 79. BioMerieux Basic Information, Manufacturing Base and Competitors
Table 80. BioMerieux Major Business
Table 81. BioMerieux Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 82. BioMerieux Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. BioMerieux Recent Developments/Updates
Table 84. BioMerieux Competitive Strengths & Weaknesses
Table 85. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 86. Bio-Rad Laboratories Major Business
Table 87. Bio-Rad Laboratories Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 88. Bio-Rad Laboratories Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Bio-Rad Laboratories Recent Developments/Updates
Table 90. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 91. Assure Tech Basic Information, Manufacturing Base and Competitors
Table 92. Assure Tech Major Business
Table 93. Assure Tech Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 94. Assure Tech Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Assure Tech Recent Developments/Updates
Table 96. Assure Tech Competitive Strengths & Weaknesses
Table 97. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 98. Guangzhou Wondfo Biotech Co.,Ltd. Major Business
Table 99. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 100. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
Table 102. Guangzhou Wondfo Biotech Co.,Ltd. Competitive Strengths & Weaknesses
Table 103. Wuhan Easy Diagnosis Basic Information, Manufacturing Base and Competitors
Table 104. Wuhan Easy Diagnosis Major Business
Table 105. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 106. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Wuhan Easy Diagnosis Recent Developments/Updates
Table 108. Wuhan Easy Diagnosis Competitive Strengths & Weaknesses
Table 109. Getein Biotech Basic Information, Manufacturing Base and Competitors
Table 110. Getein Biotech Major Business
Table 111. Getein Biotech Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 112. Getein Biotech Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Getein Biotech Recent Developments/Updates
Table 114. Getein Biotech Competitive Strengths & Weaknesses
Table 115. Beijing Hotgen Biotech Co.,ltd. Basic Information, Manufacturing Base and Competitors
Table 116. Beijing Hotgen Biotech Co.,ltd. Major Business
Table 117. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 118. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
Table 120. Beijing Hotgen Biotech Co.,ltd. Competitive Strengths & Weaknesses
Table 121. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 122. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Major Business
Table 123. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 124. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Recent Developments/Updates
Table 126. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Competitive Strengths & Weaknesses
Table 127. Qingdao Hightop Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 128. Qingdao Hightop Biotech Co., Ltd. Major Business
Table 129. Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 130. Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Qingdao Hightop Biotech Co., Ltd. Recent Developments/Updates
Table 132. Qingdao Hightop Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 133. Goldsite Diagnostics Inc. Basic Information, Manufacturing Base and Competitors
Table 134. Goldsite Diagnostics Inc. Major Business
Table 135. Goldsite Diagnostics Inc. Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 136. Goldsite Diagnostics Inc. Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Goldsite Diagnostics Inc. Recent Developments/Updates
Table 138. Goldsite Diagnostics Inc. Competitive Strengths & Weaknesses
Table 139. Genrui Biotech Inc Basic Information, Manufacturing Base and Competitors
Table 140. Genrui Biotech Inc Major Business
Table 141. Genrui Biotech Inc Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 142. Genrui Biotech Inc Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Genrui Biotech Inc Recent Developments/Updates
Table 144. Hipro Biotechnology CO.,LTD Basic Information, Manufacturing Base and Competitors
Table 145. Hipro Biotechnology CO.,LTD Major Business
Table 146. Hipro Biotechnology CO.,LTD Point-of-care Testing (POCT) for Inflammatory Product and Services
Table 147. Hipro Biotechnology CO.,LTD Point-of-care Testing (POCT) for Inflammatory Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Point-of-care Testing (POCT) for Inflammatory Upstream (Raw Materials)
Table 149. Point-of-care Testing (POCT) for Inflammatory Typical Customers
Table 150. Point-of-care Testing (POCT) for Inflammatory Typical Distributors
LIST OF FIGURES
Figure 1. Point-of-care Testing (POCT) for Inflammatory Picture
Figure 2. World Point-of-care Testing (POCT) for Inflammatory Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Point-of-care Testing (POCT) for Inflammatory Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Point-of-care Testing (POCT) for Inflammatory Production (2018-2029) & (K Units)
Figure 5. World Point-of-care Testing (POCT) for Inflammatory Average Price (2018-2029) & (US$/Unit)
Figure 6. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Region (2018-2029)
Figure 7. World Point-of-care Testing (POCT) for Inflammatory Production Market Share by Region (2018-2029)
Figure 8. North America Point-of-care Testing (POCT) for Inflammatory Production (2018-2029) & (K Units)
Figure 9. Europe Point-of-care Testing (POCT) for Inflammatory Production (2018-2029) & (K Units)
Figure 10. China Point-of-care Testing (POCT) for Inflammatory Production (2018-2029) & (K Units)
Figure 11. Japan Point-of-care Testing (POCT) for Inflammatory Production (2018-2029) & (K Units)
Figure 12. Point-of-care Testing (POCT) for Inflammatory Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029) & (K Units)
Figure 15. World Point-of-care Testing (POCT) for Inflammatory Consumption Market Share by Region (2018-2029)
Figure 16. United States Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029) & (K Units)
Figure 17. China Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029) & (K Units)
Figure 18. Europe Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029) & (K Units)
Figure 19. Japan Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029) & (K Units)
Figure 20. South Korea Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029) & (K Units)
Figure 22. India Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Point-of-care Testing (POCT) for Inflammatory by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Point-of-care Testing (POCT) for Inflammatory Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Point-of-care Testing (POCT) for Inflammatory Markets in 2022
Figure 26. United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Point-of-care Testing (POCT) for Inflammatory Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Market Share 2022
Figure 30. China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Market Share 2022
Figure 32. World Point-of-care Testing (POCT) for Inflammatory Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Type in 2022
Figure 34. Based on Immunochromatography
Figure 35. Based on Chemiluminescence
Figure 36. Based on Microfluidic Chip
Figure 37. World Point-of-care Testing (POCT) for Inflammatory Production Market Share by Type (2018-2029)
Figure 38. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Type (2018-2029)
Figure 39. World Point-of-care Testing (POCT) for Inflammatory Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Point-of-care Testing (POCT) for Inflammatory Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Application in 2022
Figure 42. C-Reactive Protein (CRP) Test
Figure 43. Procalcitonin (PCT) Test
Figure 44. Interleukin 6 (IL-6) Test
Figure 45. Serum amyloid A (SAA) Test
Figure 46. Others
Figure 47. World Point-of-care Testing (POCT) for Inflammatory Production Market Share by Application (2018-2029)
Figure 48. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Application (2018-2029)
Figure 49. World Point-of-care Testing (POCT) for Inflammatory Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Point-of-care Testing (POCT) for Inflammatory Industry Chain
Figure 51. Point-of-care Testing (POCT) for Inflammatory Procurement Model
Figure 52. Point-of-care Testing (POCT) for Inflammatory Sales Model
Figure 53. Point-of-care Testing (POCT) for Inflammatory Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Point-of-care Testing (POCT) for Inflammatory Picture
Figure 2. World Point-of-care Testing (POCT) for Inflammatory Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Point-of-care Testing (POCT) for Inflammatory Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Point-of-care Testing (POCT) for Inflammatory Production (2018-2029) & (K Units)
Figure 5. World Point-of-care Testing (POCT) for Inflammatory Average Price (2018-2029) & (US$/Unit)
Figure 6. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Region (2018-2029)
Figure 7. World Point-of-care Testing (POCT) for Inflammatory Production Market Share by Region (2018-2029)
Figure 8. North America Point-of-care Testing (POCT) for Inflammatory Production (2018-2029) & (K Units)
Figure 9. Europe Point-of-care Testing (POCT) for Inflammatory Production (2018-2029) & (K Units)
Figure 10. China Point-of-care Testing (POCT) for Inflammatory Production (2018-2029) & (K Units)
Figure 11. Japan Point-of-care Testing (POCT) for Inflammatory Production (2018-2029) & (K Units)
Figure 12. Point-of-care Testing (POCT) for Inflammatory Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029) & (K Units)
Figure 15. World Point-of-care Testing (POCT) for Inflammatory Consumption Market Share by Region (2018-2029)
Figure 16. United States Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029) & (K Units)
Figure 17. China Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029) & (K Units)
Figure 18. Europe Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029) & (K Units)
Figure 19. Japan Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029) & (K Units)
Figure 20. South Korea Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029) & (K Units)
Figure 22. India Point-of-care Testing (POCT) for Inflammatory Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Point-of-care Testing (POCT) for Inflammatory by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Point-of-care Testing (POCT) for Inflammatory Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Point-of-care Testing (POCT) for Inflammatory Markets in 2022
Figure 26. United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Point-of-care Testing (POCT) for Inflammatory Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Point-of-care Testing (POCT) for Inflammatory Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Market Share 2022
Figure 30. China Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Inflammatory Production Market Share 2022
Figure 32. World Point-of-care Testing (POCT) for Inflammatory Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Type in 2022
Figure 34. Based on Immunochromatography
Figure 35. Based on Chemiluminescence
Figure 36. Based on Microfluidic Chip
Figure 37. World Point-of-care Testing (POCT) for Inflammatory Production Market Share by Type (2018-2029)
Figure 38. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Type (2018-2029)
Figure 39. World Point-of-care Testing (POCT) for Inflammatory Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Point-of-care Testing (POCT) for Inflammatory Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Application in 2022
Figure 42. C-Reactive Protein (CRP) Test
Figure 43. Procalcitonin (PCT) Test
Figure 44. Interleukin 6 (IL-6) Test
Figure 45. Serum amyloid A (SAA) Test
Figure 46. Others
Figure 47. World Point-of-care Testing (POCT) for Inflammatory Production Market Share by Application (2018-2029)
Figure 48. World Point-of-care Testing (POCT) for Inflammatory Production Value Market Share by Application (2018-2029)
Figure 49. World Point-of-care Testing (POCT) for Inflammatory Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Point-of-care Testing (POCT) for Inflammatory Industry Chain
Figure 51. Point-of-care Testing (POCT) for Inflammatory Procurement Model
Figure 52. Point-of-care Testing (POCT) for Inflammatory Sales Model
Figure 53. Point-of-care Testing (POCT) for Inflammatory Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
